Transconjunctival Sutureless Intrascleral Fixation of Secondary Intraocular Lenses in Patients with Uveitis. Todorich B, Thanos A, Yonekawa Y, Thomas BJ, Abbey AM, Faia LJ.Journal of Ophthalmic and Vision Research. Chorioretinal Coloboma Complications: Retinal Detachment and Choroidal Neovascular Membrane. Hussain RM, Abbey AM, Shah AR, Drenser KA, Trese MT, Capone A Jr.Stalagmite- like Preretinal Inflammatory Deposits in Vitrectomized Eyes with Posterior Uveitis. Yonekawa Y, Abbey AM, van Laere L, Shah AR, Thomas BJ, Ruby AJ, Faia LJ.Prevalence and Surgical Outcomes of Macular Hole in Eyes with Age-Related Macular Degeneration. Rao P, Yonekawa Y, Abbey AM, Shah AA, Wolfe JD, Faia LJ.Co-Investigator, A Phase 3, Open-label Safety Study of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in Patients with Non-Infectious Uveitis – Clearside CLS 1001-302.Co-Investigator, Multi-Center, Non-interventional Extension Study of the Safety and Efficacy of CLS-TA for the Treatment of Macular Edema Associated with Non- Infectious Uveitis Clearside CLS 1001-301.Hoffman-La Roche Ltd BP29647 AVENUE Study. Co-Investigator, A Multiple-center, Multiple-dose, Active Comparator-controlled, Double-masked, Study to Evaluate the Safety and Efficacy of RO6867461 Administered Intravitreally in Patients with Choroidal Neovascularization Secondary to Age-Related Macular Degeneration F.Co-Investigator, A Multi-center, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Lampalizumab in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration who Have Completed a Roche- Sponsored Study F.Principal Investigator, A Phase 2, Randomized, Double-masked, Active-controlled, Phase 2 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal REGN910-3 in patients with Diabetic Macular Edema Regeneron Pharmaceuticals R910- RUBY Study.Principal Investigator, A Phase 2, Randomized, Double-masked, Active-controlled Phase 2 Study of the Efficacy, Safety, and Tolerability of Repeated Doses of Intravitreal REGN910-3 in Patients with Neovascular Age-Related Macular Degeneration Regeneron Pharmaceuticals R910- ONYX Study.Principal Investigator, A Phase 3, Randomized, Masked, Controlled Trial to Study the Safety and Efficacy of Suprachoroidal CLS-TA in conjunction with Intravitreal Aflibercept in Subjects with Retinal Vein Occlusion Clearside CLS1003-301 SAPPHIRE Study.Principal Investigator, A Phase 2, Multi-center, Randomized, Double-masked, Placebo- controlled, Pilot Study to Evaluate Effects of Emixustat Hydrochloride on Aqueous Humor Biomarkers Associated with Proliferative Diabetic Retinopathy Acucela Protocol 4429-203.Principal Investigator, A Phase 2, Randomized, Double-masked, Controlled Study comparing the Safety and Efficacy of Suprachoroidal CLS-TA with Intravitreal Aflibercept versus Aflibercept alone in Subjects with Diabetic Macula Edema Clearside CLS 2004-201 TYBEE Study.Principal Investigator, A Phase 3, Double-Masked, Randomized Study of the Efficacy and Safety of Intravitreal Aflibercept Injection in Patients with Moderately Severe to Severe Non-proliferative Diabetic Retinopathy Protocol # VEGFTe-OD-1411 PANORAMA Study.Chang enjoys the culinary arts, activities at church, and spending time with his wife and two kids. He has been consistently selected by his peers as a Houston Super Doctor, Houstonia Magazine Top Doctor, as well as H-Texas Magazine Top Doctor several years in a row.Įmmanuel is fluent in English, Mandarin, and conversational Spanish. His current research focus is on artificial nanophotoreceptor technologies and integrating nanotechnology within the field of ophthalmology. He also specializes in acquired/inherited pediatric retinal disorders including retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, Coats’ disease, congenital cataracts, and complex cataract surgeries/dislocated intraocular lenses. He has participated in numerous clinical trials and received multiple research grants and is a member of the Retina Society and Association of Pediatric Retinal Surgeons.ĭr Chang specializes in all aspects of adult and pediatric vitreoretinal diseases with a particular interest in macular diseases such as puckers, macular holes and age related macular degeneration, retinal detachments, diabetic retinopathy, and vein occlusions. Michels fellowship award, the nation’s highest honor given to a retina surgical fellow. He was awarded the Heed Ophthalmic Fellowship Award and the Ronald G. Tarek Hassan and 6 other distinguished retina faculty. He had the privilege of completing his vitreoretinal surgical fellowship at the world-renowned retinal surgical training program, Associated Retinal Consultants/William Beaumont Hospital in Michigan, under the guidance of Dr. Chang is a board certified ophthalmologist.
0 Comments
Leave a Reply. |